Buffalo (1)

Allogeneic Hematopoietic Stem Cell Transplantation Recipient (1)

Blasts 5 Percent or More of Bone Marrow Nucleated Cells (1)

Blasts 5 Percent or More of Peripheral Blood White Cells (1)

CD22 Positive (1)

Lymphoblasts 20 Percent or More of Bone Marrow Nucleated Cells (1)

Lymphoblasts 20 Percent or More of Peripheral Blood White Cells (1)

Recurrent B Acute Lymphoblastic Leukemia (1)

Refractory B Acute Lymphoblastic Leukemia (1)

Withdrawn (1)

phase 1/phase 2 (1)

Roswell Park Cancer Institute (1)

Pfizer (1)

inotuzumab ozogamicin (1)

quality-of-life assessment (1)

vincristine sulfate liposome (1)

biological (1)

drug (1)

other (1)

Other (1)

Interventional (1)

lymphoblasts 20 percent or more of bone marrow nucleated cells

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Withdrawn

Jan 13, 2022